Skip to main content
Advisory or UpdateCOVID-19Emerging Diseases and ConditionsHealth AdvisoryImmunizationInfection Control

12/17/2021 Health Advisory: Updated J&J Vaccine Recommendations

By December 17, 2021December 21st, 2021No Comments

Requested actions

Background

On Dec. 16, CDC endorsed Advisory Committee on Immunization Practices’ (ACIP’s) recommendation to express clinical preference for mRNA COVID-19 vaccines (Pfizer and Moderna) over J&J COVID-19 vaccine for all people 18 years or older. ACIP voted unanimously following a review and discussion of the latest evidence showing 54 reports of people developing TTS after getting J&J COVID-19 vaccine. Of these, 36 required intensive care and 9 people died. CDC has seen TTS in all age groups and genders, but it is most common in women 30–50 years old. TTS occurred in 3.8 per 1 million doses, with 0.5 fatalities per 1 million doses.

CDC opted to leave J&J COVID-19 vaccine as an option for people 18 years or older because it is accessible, and some people feel concern about the perceived novelty of mRNA vaccines. Canada and the United Kingdom issued similar guidance.

Supplies of mRNA COVID-19 vaccines are abundant in the United States. If a patient is unable or unwilling to get mRNA COVID-19 vaccine, offer J&J COVID-19 vaccine. Any approved vaccine is better than none.

Additional information

On Dec. 17, CDC hosted a Clinician Outreach and Communication Activity (COCA) call about the latest evidence on TTS after getting J&J COVID-19 vaccine. Presenters discussed TTS and updated vaccine recommendations. If you were unable to attend the call, you can view a recording on CDC’s COCA call page.

COVID-19 vaccine

COVID-19 testing

COVID-19 therapeutics

Department of Health and Human Services (HHS) allocates monoclonal antibody and oral antiviral supplies to each state. DOH distributes doses to enrolled providers. Providers must enroll in Healthcare Partner Ordering Portal (HPoP) to manage COVID-19 therapeutics. Email mcm@doh.wa.gov to register for HPoP training, held on Tuesdays at 9 a.m.

COVID-19 prevention patient education

Share the following materials with patients.

Immediately report COVID-19

We ask that you notify us of patients being tested who are hospitalized or have contact with a confirmed case, and not wait for the lab confirmation. Fax the COVID-19 Report Form to 360-778-6103. You can leave us a non-urgent confidential report on our 24-hour Communicable Disease Report Line, 360-778-6150.

Contacting the Health Department

360-778-6100        Main Call Line – available M-F 8:30am to 4:30pm

360-715-2588        Afterhours Answering Service – available after 4:30pm and weekends

360-778-6150        Communicable Disease Report Line – 24 hours a day 7 days a week

360-778-6103        Confidential Communicable Disease Fax – 24 hours a day 7 days a week

Additional resources